$GBLX
GB SCIENCES INC

2022 Q3 Form 10-Q Financial Statement

#000143774922020177 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $275.8K $459.5K $451.0K
YoY Change -32.98% -6.87% 39.14%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.40K $20.09K $17.07K
YoY Change 14.99% 15.79% -1.04%
% of Gross Profit
Operating Expenses $275.8K $459.5K $451.0K
YoY Change -32.98% -6.87% 39.13%
Operating Profit -$275.8K -$459.5K -$451.0K
YoY Change -32.97% -6.87% 39.13%
Interest Expense $37.22K $38.57K -$154.8K
YoY Change -60.92% -40.89% 336.4%
% of Operating Profit
Other Income/Expense, Net -$37.22K -$38.57K $15.64K
YoY Change -56.85% -40.89% -56.37%
Pretax Income -$313.1K -$498.1K -$3.608M
YoY Change -37.11% -10.84% 1014.56%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$313.1K -$498.1K -$3.668M
YoY Change -43.68% -21.24% 665.97%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$904.10 -$1.529K -$11.47K
COMMON SHARES
Basic Shares Outstanding 330.2M 325.7M 317.4M
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $657.8K $53.96K $233.9K
YoY Change 66.38% -90.74% -70.51%
Cash & Equivalents $657.8K $53.96K $233.9K
Short-Term Investments
Other Short-Term Assets $220.7K $56.41K $93.93K
YoY Change -90.04% -97.78% -96.59%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $878.5K $110.4K $327.8K
YoY Change -66.36% -96.47% -90.75%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $2.239M $2.230M $2.222M
YoY Change -69.41% -69.04% -69.4%
TOTAL ASSETS
Total Short-Term Assets $878.5K $110.4K $327.8K
Total Long-Term Assets $2.239M $2.230M $2.222M
Total Assets $3.117M $2.341M $2.550M
YoY Change -68.61% -77.34% -76.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.582M $1.768M $1.657M
YoY Change -0.2% 20.77% 17.31%
Accrued Expenses $17.07K $48.77K $9.627K
YoY Change -98.56% -95.27% -99.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.170M $989.9K $987.6K
YoY Change -68.51% -72.65% -72.53%
Total Short-Term Liabilities $4.091M $4.108M $3.935M
YoY Change -53.75% -52.82% -54.23%
LONG-TERM LIABILITIES
Long-Term Debt $219.6K $398.1K $397.3K
YoY Change -31.3% 30.15% 35.87%
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $219.6K $398.1K $397.3K
YoY Change -93.94% -89.1% -89.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.091M $4.108M $3.935M
Total Long-Term Liabilities $219.6K $398.1K $397.3K
Total Liabilities $4.311M $4.506M $4.333M
YoY Change -65.43% -63.54% -64.72%
SHAREHOLDERS EQUITY
Retained Earnings -$105.4M -$105.1M -$104.6M
YoY Change 0.15% 0.38% 0.67%
Common Stock $37.82K $32.92K $32.50K
YoY Change 19.15% 3.71% 3.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.193M -$2.166M -$1.783M
YoY Change
Total Liabilities & Shareholders Equity $3.117M $2.341M $2.550M
YoY Change -68.61% -77.34% -76.4%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$313.1K -$498.1K -$3.668M
YoY Change -43.68% -21.24% 665.97%
Depreciation, Depletion And Amortization $20.40K $20.09K $17.07K
YoY Change 14.99% 15.79% -1.04%
Cash From Operating Activities -$615.5K -$292.0K -$665.2K
YoY Change 352.99% -54.12% -28.63%
INVESTING ACTIVITIES
Capital Expenditures -$30.32K $0.00 -$100.0K
YoY Change -39.36% -100.0% -400.12%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Cash From Investing Activities -$30.32K $0.00 -$100.0K
YoY Change -45.8% -100.0% -264.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $125.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.250M $112.1K -505.2K
YoY Change 7936.27% 284.18% -146.12%
NET CHANGE
Cash From Operating Activities -615.5K -$292.0K -665.2K
Cash From Investing Activities -30.32K $0.00 -100.0K
Cash From Financing Activities 1.250M $112.1K -505.2K
Net Change In Cash 603.8K -$179.9K -1.270M
YoY Change -442.54% -60.01% -666.45%
FREE CASH FLOW
Cash From Operating Activities -$615.5K -$292.0K -$665.2K
Capital Expenditures -$30.32K $0.00 -$100.0K
Free Cash Flow -$585.2K -$292.0K -$565.2K
YoY Change 581.42% -50.21% -41.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
124288 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
104201 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
1765 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
85279 usd
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
99489 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
329205891
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
329205891
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
325037557
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
325037557
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
000-55462
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-3733133
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
3550 W. Teco Avenue
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89118
CY2022Q2 dei City Area Code
CityAreaCode
866
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
721-0297
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38572 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-65254 usd
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
330205891
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53960 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233893 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
56413 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
93933 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
110373 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
327826 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2230222 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2222074 usd
CY2022Q2 us-gaap Assets
Assets
2340595 usd
CY2022Q1 us-gaap Assets
Assets
2549900 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1767826 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1657008 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
405254 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
384769 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48772 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9627 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
989845 usd
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
987565 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
896495 usd
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
896495 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4108192 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3935464 usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
398114 usd
CY2022Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
397308 usd
CY2022Q2 us-gaap Liabilities
Liabilities
4506306 usd
CY2022Q1 us-gaap Liabilities
Liabilities
4332772 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
32921 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
32504 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102879579 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102764746 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105078211 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104580122 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2165711 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1782872 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2340595 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2549900 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
459517 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
493405 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-459517 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-493405 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
38572 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
65254 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-498089 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-558659 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-498089 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-558659 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-73758 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-498089 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-632417 usd
CY2022Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-498089 usd
CY2021Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-558659 usd
CY2022Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
0 usd
CY2021Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-73758 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-498089 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-632417 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.00
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.00
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
325743436
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
315675539
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-498089 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-632417 usd
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 usd
CY2021Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-73758 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-498089 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-558659 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
20086 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17354 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6500 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
19500 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15976 usd
CY2021Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
37849 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-37520 usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
39830 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
66334 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10304 usd
CY2022Q2 gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
39145 usd
CY2021Q2 gblx Increase Decrease In Accrued Liabilities Excluding Interest Payable
IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable
-126943 usd
CY2022Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
20485 usd
CY2021Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
27404 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-292043 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-633629 usd
CY2022Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
CY2021Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2954 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-292043 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-636583 usd
CY2022Q2 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
0 usd
CY2021Q2 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
200000 usd
CY2022Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2021Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
50000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
150000 usd
CY2022Q2 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0 usd
CY2021Q2 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
7435 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
157435 usd
CY2022Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2021Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
62660 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
125000 usd
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-12890 usd
CY2021Q2 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
112110 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
62660 usd
CY2022Q2 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 usd
CY2021Q2 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-33478 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
112110 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29182 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-179933 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-449966 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
233893 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1145633 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53960 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
695667 usd
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
-0 usd
CY2021Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
112696 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53960 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
582971 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
2111 usd
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
241014 usd
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2021Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q2 gblx Depreciation Capitalized In Inventory
DepreciationCapitalizedInInventory
0 usd
CY2021Q2 gblx Depreciation Capitalized In Inventory
DepreciationCapitalizedInInventory
134511 usd
CY2022Q2 gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
28234 usd
CY2021Q2 gblx Patent Filing And Drafting Costs Capitalized In Intangible Assets
PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets
55385 usd
CY2022Q2 gblx Accrued Brokerage Fees For Common Stock Issuances And Warrant Exercises
AccruedBrokerageFeesForCommonStockIssuancesAndWarrantExercises
16250 usd
CY2021Q2 gblx Accrued Brokerage Fees For Common Stock Issuances And Warrant Exercises
AccruedBrokerageFeesForCommonStockIssuancesAndWarrantExercises
6266 usd
CY2022Q2 gblx Induced Dividend From Exercise Of Warrants
InducedDividendFromExerciseOfWarrants
0 usd
CY2021Q2 gblx Induced Dividend From Exercise Of Warrants
InducedDividendFromExerciseOfWarrants
163016 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1782872 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
108750 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6500 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-498089 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2165711 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1473928 usd
CY2021Q2 gblx Exercise Of Warrants For Stock Value
ExerciseOfWarrantsForStockValue
56394 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19500 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-632417 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2030451 usd
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><i><b>Use of Estimates</b></i></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation, other loss contingencies, and impairment of long lived assets.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <em style="font: inherit;">not</em> readily apparent from other sources. The actual results the Company experiences <em style="font: inherit;"> may </em>differ materially and adversely from these estimates.</p>
CY2022Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><i><b>Reclassifications</b></i></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><em style="font: inherit;">No</em> reclassifications to the comparative period amounts were necessary in order to conform to the current period presentation.</p>
CY2022Q2 gblx Indefinitelived Intangible Assets Pending Number
IndefinitelivedIntangibleAssetsPendingNumber
18 pure
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
123013087
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
160314865
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105078211 usd
CY2022Q2 gblx Working Capital Deficit
WorkingCapitalDeficit
3997819 usd
CY2022Q1 gblx Working Capital Deficit
WorkingCapitalDeficit
3607638 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-292043 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-636583 usd
CY2021Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2954 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
108750 usd

Files In Submission

Name View Source Status
0001437749-22-020177-index-headers.html Edgar Link pending
0001437749-22-020177-index.html Edgar Link pending
0001437749-22-020177.txt Edgar Link pending
0001437749-22-020177-xbrl.zip Edgar Link pending
ex_394471.htm Edgar Link pending
ex_394472.htm Edgar Link pending
ex_394473.htm Edgar Link pending
ex_394474.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gblx-20220630.xsd Edgar Link pending
gblx20220630_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
gblx-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gblx-20220630_def.xml Edgar Link unprocessable
gblx-20220630_lab.xml Edgar Link unprocessable
gblx-20220630_pre.xml Edgar Link unprocessable
gblx20220630_10q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending